{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"OneMedicine Podcast","title":"Understanding the Gut-Lung Axis and How to Restore Respiratory Health Through the Gut Microbiome","html":"","width":"100%","height":180,"duration":2565,"description":"In this episode of the OneMedicine Podcast, Kara Siedman, a registered dietitian, and Dr. Vivek Lal, the founder and CEO of ResBiotic, joined Rob Lutz for an in-depth discussion on the gut-lung axis and how the microbiome can impact respiratory and metabolic health. They covered:·         The importance of the gut microbiome as the \"foundation\" for overall health and resilience·         How specific probiotic strains and botanical blends can support lung function and reduce inflammation·         The concept of \"postbiotics\" and how they can naturally support metabolic markers like GLP-1·         The need for rigorous scientific research and clinical validation in the supplement industryKara and Vivek emphasized the value of taking a targeted, precision approach to supporting the microbiome, rather than generic, one-size-fits-all supplements. They challenged practitioners to consider the microbiome as a central hub that connects various body systems. Links: ResBiotic Nutrition  - https://resbiotic.com  Bios: Dr. C. Vivek Lal, MD, FAAP is a physician scientist and innovator based in Birmingham, AL, USA. Dr. Lal is a double board-certified physician, having completed medical school, residency training and clinical fellowship in neonatal and perinatal medicine. He also completed a research fellowship in pulmonary and vascular biology from UT Southwestern Medical Center, Dallas, TX and executive program in drug and device development from MIT, Boston, MA. On the academic side, Dr. Lal serves as Director of Clinical Innovation at The Marnix Heersink Institute of Biomedical Innovation at the University of Alabama at Birmingham (UAB) and is the Director of Pulmonary Microbiome Lab.  Dr. Lal is a serial entrepreneur, and Founder of Biostack Ventures through which he launched successful companies such as ResBiotic Nutrition which makes consumer probiotics, Alveolus Bio which does FDA approved pulmonary drug development. Dr. Lal also co-founded and serves on the Board for...","thumbnail_url":"https://img.transistorcdn.com/CoKoqV3-mQVlE9NhErjAkuZekrptJoRFzOiUbKHwUV0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQ4NTgyLzE3MDQ5/MjIwNzEtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}